< Back to previous page
Researcher
Ruth De Bruyne
- Keywords:Pediatric hepatology, Health care transition in rare disease, metabolic dysfunction-associated steatotic liver disease, Rare liver diseases
- Disciplines:Hepatology (incl. pancreas), Paediatrics
Affiliations
- Department of Internal Medicine and Pediatrics (Department)
Member
From1 Sep 2019 → Today - Department of Otorhinolaryngology (Department)
Member
From28 May 2009 → 25 Sep 2016
Projects
1 - 4 of 4
- Exercise as medicine for mitochondrial health: the muscle-liver axis in pediatric obesity and steatotic liver disease.From1 Jan 2025 → TodayFunding: BOF - projects
- Exercise as medicine for mitochondrial health: the muscle-liver axis in pediatric obesity and steatotic liver disease.From1 Jan 2024 → 31 Dec 2024Funding: BOF - projects
- The crosstalk between liver and muscle in pediatric non-alcoholic fatty liver disease: target for a healthier future.From1 Oct 2023 → TodayFunding: FWO fundamental clinical research fellowship
- ERN RARE-LIVERFrom1 Oct 2023 → TodayFunding: Other EU initiatives out of framework
Publications
1 - 10 of 143
- A repository of the salivary metabolome and its key drivers in 1436 European children(2025)Published in: EBIOMEDICINEISSN: 2352-3964Volume: 122
- Post‐transplant metabolic syndrome in pediatric liver transplant recipients : definition, prevalence and clinical presentation(2025)Published in: PEDIATRIC TRANSPLANTATIONISSN: 1399-3046Issue: 8Volume: 29
- Mitochondrial dysfunction characterises the multigenerational effects of maternal obesity on MASLD(2025)Published in: JHEP REPORTSISSN: 2589-5559Issue: 6Volume: 7
- Variability in the management of portal hypertension across European countries : a survey‐study by ESPGHAN Portal Hypertension Special Interest Group(2025)Published in: JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITIONISSN: 1536-4801Issue: 3Volume: 81Pages: 674 - 678
- The impact of cardiopulmonary fitness on metabolic dysfunction-associated steatotic liver disease in a combined lifestyle intervention for adolescents with obesity(2025)Volume: 82Pages: S511 - S511
- Neonatal cholestasis progressing to a multisystem syndrome with liver cirrhosis in two siblings with FARSA deficiency : an evolving hepatological phenotype(2025)Published in: JIMD REPORTSISSN: 2192-8312Issue: 3Volume: 66
- Post‐transplant metabolic syndrome in pediatric liver transplant recipients : contributors, screening, and management(2025)Published in: PEDIATRIC TRANSPLANTATIONISSN: 1399-3046Issue: 8Volume: 29
- Reply : development and validation of pFIB scores for exclusion of significant liver fibrosis in pediatric MASLD(2025)Published in: HEPATOLOGYISSN: 1527-3350Issue: 4Volume: 81Pages: E119 - E120
- The association of ultra‐processed food intake with adolescent metabolic dysfunction‐associated steatotic liver disease in the NHANES(2025)Published in: PEDIATRIC OBESITYISSN: 2047-6310Issue: 4Volume: 20
- The pan-PPAR agonist lanifibranor reduces portal pressure independent of fibrosis reduction through the splanchnic vasculature(2025)Published in: BIOMEDICINE & PHARMACOTHERAPYISSN: 1950-6007Volume: 183